Alpha Modus (AMOD) Sues Walgreens for Patent Infringement
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- AMD shares fall amid AI chip sector selloff
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
Alpha Modus Sues Walgreens for Patent Infringement, Strengthening Its Leadership in AI-Driven Retail Innovation
February 4, 2025 8:00 AM ESTCORNELIUS, N.C., Feb. 04, 2025 (GLOBE NEWSWIRE) -- Alpha Modus Holdings, Inc. (Nasdaq: AMOD) (Company) announced today that its wholly owned subsidiary, Alpha Modus, Corp. (Alpha Modus), has filed a patent infringement lawsuit that also alleges willful infringement against Walgreens Co. (Walgreens) in the United States District Court for the Eastern District of Texas. This legal action underscores Alpha Moduss unwavering commitment to protecting its groundbreaking AI-driven retail technology and further solidifies its leadership in the rapidly evolving retail innovation landscape.
Championing Innovation and Protecting Shareholder Value
Alpha Modus has transformed AI-powered retail engagement... More



